Deadline: 16 September 2025
The MicroMAX Collaborative Research Grants, the Novo Nordisk Foundation wishes to strengthen the user community at the MicroMAX beamline, which is located at the MAX IV Synchrotron in Lund, Sweden.
MicroMAX is a macromolecular crystallography beamline optimised for serial-synchrotron crystallography with time-resolved capabilities, see MicroMAX – MAX IV for further details about the beamline.
Goals
- The goal of the programme is to:
- Facilitate high-quality collaborative research projects at the MicroMAX beamline
- Promote the MicroMAX beamline to a Danish user community while encouraging international collaboration
- Establish expertise within serial synchrotron crystallography anchored at Danish non-profit research organisations
- Educate and train early career researchers within advanced synchrotron crystallography methods that benefit the life science ecosystem
- Advance the MicroMAX beamline’s capabilities, e.g. by the development of instrumentation and/or methods, that will benefit a large group of users
Focus Areas
- The projects should be within the Foundation’s strategic focuses on biomedicine, health sciences, sustainability, biotechnology, natural and technical sciences, or data science.
Funding Information
- A total of up to DKK 21 million is available for grants between DKK 2 million and DKK 7 million for projects with a duration between 2 and 4 years.
Eligible Expenses
- Applicants may apply for funding for the following types of expenses directly related to the project:
- Salary for academic employees in time-limited positions, e.g., PhD students, postdoctoral researchers, assistant professors without tenure-track. Salary will not be covered for applicants, co-applicants or other academic staff in time-unlimited positions.
- Salary for technical staff, e.g. laboratory technicians, data scientists and workshop staff.
- Tuition fee: For PhD students (maximum DKK 80,000 per budget year) – must be specified separately in the budget.
- Operating expenses: Consumables, materials, chemicals, utensils, data collection, analyses, computational resources etc.
- Equipment: Smaller equipment and apparatus required for the project. Vendor quotes must be included for any equipment over DKK 500,000.
Eligibility Criteria
- The main applicant must be affiliated (at least 80% of a full-time position) with a Danish university, hospital or other non-profit organisation (host institution).
- 1 or 2 co-applicants are required for the application. The co-applicant(s) can be anchored in Denmark or abroad at a university, hospital or other non-profit research institution. The co-applicant(s) should significantly contribute to the scientific advancement of the project and must receive part of the grant, as detailed in the budget.
- The main applicant and co-applicant(s) must hold a PhD degree and should be employed as assistant professor, associate professor, professor or similar academic position above the postdoctoral level.
- The use of MicroMAX capabilities, especially within serial synchrotron crystallography, including time-resolved studies, should be essential for the successful execution of the project.
- At least either the applicant or (one of) the co-applicant(s) must have expertise within synchrotron-based crystallography or closely related method(s).
- Collaboration with industry and other commercial partners is acceptable, however, funding cannot be awarded to such partners.
Ineligibility Criteria
- Commercial activities
- Overhead/indirect costs (such as rent, electricity, water and maintenance)
- Double funding of projects:
- If the applicant has received funding for the proposed project from other sources, in part or in full, this must be accounted for in the budget, as no budgetary overlaps are allowed
- If an identical or overlapping project proposal has been submitted to other funding institutions than the Foundation, it must be noted in the application
- If the applicant receives funding for the project, or parts of the project, from other sources following submission of the application to the Foundation, the Foundation must be informed immediately
For more information, visit Novo Nordisk Foundation.